The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse An open-label study of quetiapine in anorexia nervosa.
- collapse A Pilot Safety Trial to Determine the Optimal Titration Scheme for Immediate-release Quetiapine Fumarate
- collapse An open study to assess the efficacy and safety of Seroquel
- collapse An Open Label, Safety, Tolerability, and Steady State Pharmacokinetic Drug Interaction Study of the Effect of Co-administered Quetia[pine Fumarate (Seroquel ) and Divalproex Sodium (Depakote Sprinkle) in Subjects with Schizophrenic/Schizoaffective Disorders or in Subjects with Bipolar Disorder
- collapse Steady State, Dose Unit Proportionality, and Food Effect Study Using Commercial Scale Sustained Release (SR) Quetiapine Fumarate (SEROQUEL)
- collapse 5077IL/0116 Adolescent PK
- collapse An Exploratory, Multicentre, Double-blind, Double-dummy, Randomised, Parallel-group, Controlled Phase III Study to Evaluate the Safety and Tolerability of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) in Treatment of Elderly Subjects with Alzheimers Disease with Symptoms of Psychosis and/or Agitation Compared to Seroquel Immediate Release Formulation.
- collapse Efficacy and Tolerability of Olanzapine, Quetiapine and Risperidone in the Treatment of First Episode Psychosis: A Randomized Double Blind 52-Week Comparison.
- collapse SR Titration Study
- collapse A Multicentre, Open Label, Non-Comparative Trial Examining The Clinical Benefit Derived By Patients Receiving Quetiapine.
